Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives (2019)
- Authors:
- Autor USP: SANCHES JUNIOR, JOSE ANTONIO - FM
- Unidade: FM
- DOI: 10.1590/abd1806-4841.20197938
- Subjects: CERATOSE; NEOPLASIAS FACIAIS; NEOPLASIAS CUTÂNEAS; NEOPLASIAS DE CABEÇA E PESCOÇO; GEL (FORMAS FARMACÊUTICAS)
- Language: Inglês
- Imprenta:
- Publisher place: Rio De Janeiro Rj
- Date published: 2019
- Source:
- Título: Anais brasileiros de dermatologia
- ISSN: 0365-0596
- Volume/Número/Paginação/Ano: v. 94, n. 3, p. 313-319, 2019
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
GAMEIRO, Luiz et al. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives. Anais brasileiros de dermatologia, v. 94, n. 3, p. 313-319, 2019Tradução . . Disponível em: https://doi.org/10.1590/abd1806-4841.20197938. Acesso em: 12 jun. 2025. -
APA
Gameiro, L., Tovo, L. F. R., Sanches Junior, J. A., & Aprahamian, I. (2019). Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives. Anais brasileiros de dermatologia, 94( 3), 313-319. doi:10.1590/abd1806-4841.20197938 -
NLM
Gameiro L, Tovo LFR, Sanches Junior JA, Aprahamian I. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives [Internet]. Anais brasileiros de dermatologia. 2019 ; 94( 3): 313-319.[citado 2025 jun. 12 ] Available from: https://doi.org/10.1590/abd1806-4841.20197938 -
Vancouver
Gameiro L, Tovo LFR, Sanches Junior JA, Aprahamian I. Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives [Internet]. Anais brasileiros de dermatologia. 2019 ; 94( 3): 313-319.[citado 2025 jun. 12 ] Available from: https://doi.org/10.1590/abd1806-4841.20197938 - Tumores malignos de linhagem hematológica
- Imunofluorescencia direta nos penfigos vulgar e foliaceo endemico (fogo selvagem): estudo comparativo e revisao da literatura
- Reações tegumentares adversas relacionadas aos agentes antineoplásicos – Parte I
- Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology
- Erythroderma: a prospective study of 309 patients followed for 12 years in a tertiary center
- Characteristics associated with significantly worse quality of life in mycosis fungoides/Sezary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study
- Dermoscopy of primary cutaneous B- and T-cell lymphomas and pseudolymphomas presenting as solitary nodules and tumors: a case-control study with histopathologic correlation
- Characteristics and outcomes of 727 patients with mycosis fungoides and Sezary syndrome from a Brazilian cohort
- Consensuses, guidelines and position papers [Editorial]: the role of the Brazilian Society of Dermatology in the contribution to the best practice of Dermatology
- Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium (vol 28, pg 2517, 2017)
Informações sobre o DOI: 10.1590/abd1806-4841.20197938 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
